These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6055397)

  • 1. Delayed-type skin sensitivity to human encephalitogen in experimental allergic encephalomyelitis.
    August CS; Kies MW
    Nature; 1967 Jun; 214(5092):1021-2. PubMed ID: 6055397
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunologic unresponsiveness, immunity and enhancement in experimental allergic encephalomyelitis.
    Salvin SB; Liauw HL
    J Immunol; 1968 Jul; 101(1):33-42. PubMed ID: 4173936
    [No Abstract]   [Full Text] [Related]  

  • 3. CORRELATION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS WITH DELAYED-TYPE SKIN SENSITIVITY TO SPECIFIC HOMOLOGOUS ENCEPHALITOGEN.
    SHAW CM; ALVORD EC; KAKU J; KIES MW
    Ann N Y Acad Sci; 1965 Mar; 122():318-31. PubMed ID: 14313491
    [No Abstract]   [Full Text] [Related]  

  • 4. ENCEPHALITOGEN-INDUCED INHIBITION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS: PREVENTION, SUPPRESSION AND THERAPY.
    ALVORD EC; SHAW CM; HRUBY S; KIES MW
    Ann N Y Acad Sci; 1965 Mar; 122():333-45. PubMed ID: 14313493
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunologic properties of the main encephalitogenic peptide from the basic protein of human myelin.
    Lennon VA; Wilks AV; Carnegie PR
    J Immunol; 1970 Nov; 105(5):1223-30. PubMed ID: 4099924
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro demonstration of cellular sensitivity in allergic encephalomyelitis.
    David JR; Paterson PY
    J Exp Med; 1965 Dec; 122(6):1161-71. PubMed ID: 5873682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Passive transfer of experimental allergic encephalomyelitis: mechanisms of suppression.
    Falk GA; Kies MW; Alvord EC
    J Immunol; 1969 Dec; 103(6):1248-53. PubMed ID: 5361563
    [No Abstract]   [Full Text] [Related]  

  • 8. [Attempts to allergisize guinea pigs using intracerebral encephalitogen injections].
    Kupfer M; Kupfer G
    Zentralbl Allg Pathol; 1971; 114(5):521-33. PubMed ID: 5291080
    [No Abstract]   [Full Text] [Related]  

  • 9. AN ANALYSIS OF VARIOUS TYPES OF INHIBITION OF EXPERIMENTAL "ALLERGIC" ENCEPHALOMYELITIS IN THE GUINEA PIG.
    ALVORD EC; SHAW CM; FAHLBERG WJ; KIES MW
    Z Immunitats Allergieforsch; 1964 Mar; 126():217-27. PubMed ID: 14185399
    [No Abstract]   [Full Text] [Related]  

  • 10. In vivo and in vitro immunological cross-reactions between basic encephalitogen and synthetic basic polypeptides capable of suppressing experimental allergic encephalomyelitis.
    Webb C; Teitelbaum D; Arnon R; Sela M
    Eur J Immunol; 1973 May; 3(5):279-86. PubMed ID: 4128128
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental allergic encephalomyelitis: structural specificity of determinants for delayed hypersensitivity.
    Hashim GA; Sharpe RD
    Immunochemistry; 1974 Oct; 11(10):633-40. PubMed ID: 4142443
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunological reactivity of the guinea pig to autologous cerebral tissue].
    Boroş I; Bordeianu A
    Rev Roum Physiol; 1969; 6(1):63-74. PubMed ID: 5403634
    [No Abstract]   [Full Text] [Related]  

  • 13. Transformation of rodent lymphoid cells by an encephalitogen of human origin.
    Dau PC; Peterson RD
    Int Arch Allergy Appl Immunol; 1969; 35(4):353-68. PubMed ID: 5781770
    [No Abstract]   [Full Text] [Related]  

  • 14. Protective action of the encephalitogen and other basic proteins in experimental allergic encephalomyelitis.
    Rauch HC; Einstein ER; Csejtey J; Davis WJ
    Immunochemistry; 1968 Nov; 5(6):567-75. PubMed ID: 5702351
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental allergic encephalomyelitis: immunological properties of encephalitogenic polypeptides and proteins.
    Lamoureux G; Carnegie PR; McPherson TA; Johnston D
    Clin Exp Immunol; 1967 Sep; 2(5):601-9. PubMed ID: 4965043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of development of experimental allergic encephalomyelitis by encephalitogenic protein].
    Zhitnukhin IuL; Sofronov BN; Beme DKh; Baĭkovskaia MN
    Patol Fiziol Eksp Ter; 1978; (5):55-60. PubMed ID: 83596
    [No Abstract]   [Full Text] [Related]  

  • 17. A BRIEF REPORT OF A METHOD FOR PARTIAL PURIFICATION OF EAE ANTIGEN.
    THOMPSON GE
    Cornell Vet; 1965 Jan; 55():64-5. PubMed ID: 14284449
    [No Abstract]   [Full Text] [Related]  

  • 18. [ALLERGIC ENCEPHALOMYELITIS AND INTERMEDIATE ANTIGENS OF NERVE TISSUES INFECTED WITH VIRUSES].
    ADO AD; KANCHURIN AKh
    Sov Med; 1964 Jan; 27():56-66. PubMed ID: 14164801
    [No Abstract]   [Full Text] [Related]  

  • 19. Delayed hypersensitivity to myelin basic protein in the passive transfer of experimental allergic encephalomyelitis.
    Falk GA; Kies MW; Alvord EC
    J Immunol; 1968 Oct; 101(4):638-44. PubMed ID: 4971475
    [No Abstract]   [Full Text] [Related]  

  • 20. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig.
    Brod SA; al-Sabbagh A; Sobel RA; Hafler DA; Weiner HL
    Ann Neurol; 1991 Jun; 29(6):615-22. PubMed ID: 1716432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.